Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Thursday’s trading has closed, but ACAD is being traded in the after-hours session. After-Hours quote »
39.13
Delayed Data
As of 3:59pm ET
 +1.06 / +2.78%
Today’s Change
22.04
Today|||52-Week Range
51.99
+23.24%
Year-to-Date

Today’s Trading

Previous close38.07
Today’s open42.18
Day’s range38.40 - 43.50
Volume3,619,079
Average volume (3 months)1,180,732
Market cap$3.8B
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-70.79%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book12.31

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+1.18+3.96%
NBIXNeurocrine Bioscienc...-1.54-3.10%
CLVSClovis Oncology Inc-1.97-2.36%
AKRXAkorn Inc-1.12-2.83%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger G. Mills
Corporate headquarters
San Diego, California

Forecasts

Partner Offers